InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Veillon-Berteloot Chantal. Director active across 1 company, notably Integra Lifesciences Holdings CORP. Aggregated, 6 reports have been recorded. History available since 1 September 2023. The latest transaction was filed on 11 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Veillon-Berteloot Chantal is linked to Integra Lifesciences Holdings CORP, where she is EVP & CHRO. She has 6 filings in total, and in the 6 sampled filings from 2023-09-05 to 2026-03-12, the reported amounts are all tax withholding, with sum_buy_eur at 0 and sum_sell_eur at 0.